A recent meta-analysis, including over 300,000 patients with T2DM worldwide, of whom over 50,000 subjects had PAD, examined whether SGLT2 inhibitors increase the risk of LLA compared to other glucose-lowering therapies
The more accurate description is that DSIP has been studied as a sleep architecture modulator a compound that may influence the structure and quality of sleep rather than as something that switches sleep on like a hypnotic
Murthy SN, Matta AS, Mondal D, McNamara DB: Methods in assessing homocysteine metabolism
active pulmonary disease, including chronic obstructive pulmonary disease, pulmonary fibrosis, moderate-to-severe sleep apnea and moderate-to-severe asthma
(Wegovy, another semaglutide-based medication approved specifically for weight loss, uses higher doses and results in an average weight loss of 14.9 percent.) Ozempic is also prescribed off-label for weight loss in people with type 1 diabetes or those without diabetes